Clinical Group

International Journal of Immunotherapy and Cancer Research

ISSN: 2455-8591

DOI

CC By

Journal Information
  • Volume/IssueClick here
  • Review ProcessDouble Blind
    • Publication lead time3 - 4 weeks
    • Indexing statusYes; Purview
    • Manuscript Processing ChargesClick here
    • Submission ChargesNo
    • Waiver policy for APCYes
    • Language of Full TextEnglish
    • Full-text formats availablePDF, HTML
  • Show +
Best Practices
  • Type of LicenseCreative Commons
  • Open AccessYes; Policy
    • Does the author retain unrestricted copyright?Yes
    • Does the author retain publishing rights?Yes
    • Permanent article identifierDOI (Digital Object Identifier)
  • Show +
Publisher Information
  • NamePeertechz Publications Private Limited
  • Show +

Description

International Journal of Immunotherapy and Cancer Research is a multi-disciplinary peer-reviewed, open access journal. Journal brings together all the varied aspects of research that will ultimately lead to the prevention of cancer. With the goal of advancing technology and improving health

Read more

Editor-in-chief

Kwang-Hyun Baek

CHA University, Republic of Korea

Email: baek@cha.ac.kr
Tel: 82-31-881-7134
Fax: 82-31-881-7134
Skype: khb0529
More Info.

Editorial Board

Hamiyet Donmez-Altuntas
Professor
Department of Medical Biology
Erciyes University
Turkey
donmezh@erciyes.edu.tr
IJICR

Research Interest: Molecular biology, cytogenetics, genotoxicity, micronucleus, cytome assay, mutagenicity tests, gene expression, human cancer, pituitary adenomas, obesity.

More Info.
Sunandan Saha
Scientist
Bellicum Pharmaceuticals
USA
ssaha@bellicum.com
IJICR

Research Interest: My research interest involves finding innovative gene therapy solutions for human diseases. At Bellicum, Pharmaceuticals, I have played a leading role in the discovery and pre-clinical development of the CIDeCAR and Go-CART product portfolios. Prior to Bellicum, I was a trainee at Baylor College of Medicine where I developed a novel platform for delivery of erythropoietin to treat anemia associated with chronic kidney disease and evaluated the safety of the piggyBac gene delivery system for gene and cell the rapy. I have extensive research experience in immunotherapy of leukemias and solid tumors, adoptive transfer of T cells, T cell biology, tumor infiltrating lymphocytes, immune receptors biology, antigen processing and recognition, antibody therapy, tumor immunology, viral and non-viral vectors, and gene therapy of monogeneic disorders. I have comprehensive knowledge of molecular biology research techniques including genetic engineering, vector design, cloning, transfection platforms,

cytometry, biomarker development and validation and synthetic DNA construction 

More Info.
Birendra Kumar Yadav
Doctor of Philosophy
Rajiv Gandhi Cancer Institute & Research Center
India
cosmicocean@live.com
IJICR

Research Interest: signaling pathways, molecular studies and biosensor development for detection of cancer with the collaboration of nanotechnology experts.

More Info.
Guozheng Liu
Associate Professor
Department of Radiology
University of Massachusetts Medical Schoo
USA
Guozhengliu@yahoo.com
IJICR

Research Interest: Radiopharmaceutical development that involves radiolabeled agents and their evaluations both in vitro and in vivo. These agents are for disease detection, life process tracing, or tumor radiotherapy.

More Info.
Constantinos Giaginis
Assistant Professor
Department of Food Science & Nutrition
University of Aegean
Greece
cgiaginis@yahoo.gr
IJICR

Research Interest: Research areas of human physiology and pathophysiology. His research focuses on the clinical evaluation of new biomarkers and molecular mediators in several pathophysiological disease states, such as diabetes, atherosclerosis and cancer. His research interest also includes the development of quantitative structure-activity relationships (QSARs) and quantitative structure-property relationships (QSPRs) in the area of toxicology and pharmacology. Furthermore, his research interest lies in the assessment of physicochemical properties, such as lipophilicity, solubility and ionization of drugs, natural bioactive compounds and toxic chemicals in relation with their potential biological activity and toxicity endpoints, as well as their Absorption/Distribution/Metabolism/Excretion (ADME) parameters and their pharmacokinetic and toxicokinetic profiles

More Info.
Manoj Kumar
Department of Clinical Microbiology and Immunology
National Institute of Nutrition, ICMR Jamai Osmania
India
manoj15micro@yahoo.co.in
IJICR

Research Interest: Gut microbiology; Metabolic diseases; Mucosal Immunology; Cancer; Functional foods and Nutraceutical

More Info.
Tania Pencheva
Associate Professor
Department of QSAR and Molecular Modelling
Bulgarian Academy of Sciences
Bulgaria
tania.pencheva@biomed.bas.bg
IJICR

Research Interest:

• modelling, optimisation and control of biotechnological processes; 

• drug design, molecular modelling, virtual ligand screening; 

• metaheuristic algorithms; 

• intuitionistic fuzzy logic;

• generalised nets;

• intercriteria analysis in decision making systems

More Info.
Bo Jin
Professor
Department of Gastroenterology
Peoples Liberation Army
China
bjbo.jin@gmail.com
IJICR

Research Interest: His interests in liver fibrosis research focuses on the use of intrahepatic administration of collagenase for reversal of liver fibrosis and this work was one of the earliest that established proof-of-principle of these potential therapeutic agents. His immunological interest lies with double-stranded RNA induced immune response and its potential application in anti-virus and/or anti-cancer immunotherapy.

More Info.
Houria Boulaiz Tassia
Professor
Department of Human Anatomy and Embryology
University of Granada
Spain
hboulaiz@ugr.es
IJICR

Research Interest: Cancer therapy, cancer stem cells, tumour biomarkers, suicide gene therapy and antitumoral drugs, nanotechnology and regenerative medicine.

More Info.
David R. Minor
California Pacific Center for Melanoma Research and Treatment
USA
minord@sutterhealth.org
IJICR

Research Interest: Melanoma, kidney cancer , immunotherapy with ipilimumab, nivolumab, interleukin-2 and other agents. 

More Info.
Edgar Petru
Associate Professor
Department of Obstetrics and Gynecology
Medical University of Graz
Austria
edgar.petru@medunigraz.at
IJICR

Research Interest: Gynecologic oncology, chemotherapy, immunotherapy, targeted therapy, systemic therapy, Supportive therapy

More Info.
Barbara Wollenberg
Professor
Department of Otorhinolaryngology
Universitatsklinikum Schleswig-Holstein
Germany
Barbara.Wollenberg@uksh.de
IJICR

Research Interest: Head and neck oncology, molecular as well as clinically molecular rhinology

More Info.
Rongxin Zhang
Professor
Laboratory of Immunology and Inflammatory Diseases
Tianjin Medical University
China
rongxinz@yahoo.com
IJICR

Research Interest: My research interests are from basic immunology science to translational medicine in following immune associated area/diseases.

1. Cancer Immunology and nano-medicine

2. Obesity and Immunity

3. Neuro-immunology (autoimmune induced central nervous system inflammation)

4. Immunity to Infectious Diseases and Vaccines


More Info.
Luis Corrales-Rodriguez
Assistant Professor
University of Costa Rica
Central America
corrales@cimcacr.com
IJICR

Research Interest: Thoracic Oncology, Translational Research, Immuno-Oncology

More Info.
Monica Rinaldi
Research Scientist
Department of BioMedicine
National Research Council
Italy
monica.rinaldi@ift.cnr.it
IJICR

Research Interest: Development of new DNA vaccines and adjuvants for anticancer therapy and/or prevention, intended for clinical application. Preclinical protocols of genetic immunization against tumor-associated antigens Combined therapeutic protocols (vaccination+immunotherapy+chemotherapy) in preclinical research.

More Info.
View more

Osteotropism of Breast and Prostate Cancer: Clinical and Experimental Perspective

Published On: May 20, 2017 | Pages: 032 - 033

Author(s): Manuel Scimeca#, Francesca Starace#, Deborah Gratti, Viviana Benedicta Sapia, Rita Bonfi glio and Elena Bonanno*
View Article DOI: 10.17352/2455-8591.000016

Immunomodulatory Effects of Food Additives

Published On: April 17, 2017 | Pages: 019 - 031

Author(s): Hamid Y Dar, Shivani Chaturvedi, Karishma Srivastava, Zaffar Azam, Rajaneesh Anupam, Rajesh K Mondal, Geetanjali B Tomar, Ashish K Singh, Pradyumna K Mishra and Rupesh K Srivastava*
View Article DOI: 10.17352/2455-8591.000015

A Study of Glucosylceramide Synthase and Glycolytic Pathway Enzymes in Patients with Hypereosinophilia

Published On: March 31, 2017 | Pages: 015 - 018

Author(s): Lisa Redmond, Paul Kennedy, Colm Buckley and Philip T Murphy*
View Article DOI: 10.17352/2455-8591.000014

A Very Rare Case of Polycythemia Vera Patient Who Developed Other Four Cancers

Published On: February 03, 2017 | Pages: 012 - 014

Author(s): Romeo-Gabriel Mihaila*
View Article DOI: 10.17352/2455-8591.000013

Immunosuppressive and Cytotoxic Potential of Flavonoids from Medicinal Plants: Preliminary Investigation for Anticancer Activity

Published On: February 01, 2017 | Pages: 007 - 011

Author(s): Amit Gupta* and Revati N Chavan
View Article DOI: 10.17352/2455-8591.000012

Dalton’s Lymphoma as a Murine Model for Understanding the Progression and Development of T-Cell Lymphoma and Its Role in Drug Discovery

Published On: February 01, 2017 | Pages: 001 - 006

Author(s): Raj Kumar Koiri*, Aditi Mehrotra and Surendra Kumar Trigun
View Article DOI: 10.17352/2455-8591.000011

Significance of Cancer Stem Cells in Anti-Cancer Therapies

Published On: December 31, 2016 | Pages: 014 - 016

Author(s): Mónica Botelho* and Helena Alves
View Article DOI: 10.17352/2455-8591.000010

A Synchronous Presentation of AITL with Adenocarcinoma of Lung

Published On: October 06, 2016 | Pages: 011 - 013

Author(s): Kanagaraja Karunakaran Parathan*
View Article DOI: 10.17352/2455-8591.000009

Cytokine Production and Human Cytomegalovirus Load in Allogeneic Hematopoietic Stem Cell Transplantation Outcome

Published On: June 17, 2016 | Pages: 003 - 010

Author(s): TA Silva**, JF Correia-Silva, RG Resende, MHNG Abreu, AL Teixeira, H Bittencourt, RS Gomez
View Article DOI: 10.17352/2455-8591.000008

Endothelial Progenitor Cells in Breast Cancer

Published On: January 23, 2016 | Pages: 001 - 002

Author(s): Monica C Botelho*, Helena Alves
View Article DOI: 10.17352/2455-8591.000007
TOP